ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026)
ENvue Medical (FEED) reported Net Income towards Common Stockholders of -$22.6 million for Q1 2026, down 1108.39% year-over-year from $2.2 million in Q1 2025, and down 66.05% quarter-over-quarter from -$13.6 million in Q4 2025.
ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has 13 years of Net Income towards Common Stockholders data on file, last reported at -$22.6 million in Q1 2026.
- Net Income towards Common Stockholders for Q1 2026 came in at -$22.6 million, down 1108.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$37.5 million (down 652.13% YoY), and the FY2025 annual result was -$16.8 million, down 352.77% from the prior year.
- Net Income towards Common Stockholders fell to -$22.6 million in Q1 2026 per FEED's latest filing, from -$13.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$500000.0 in Q2 2025 and troughed at -$22.6 million in Q1 2026.
- A 5-year average of -$3.1 million and a median of -$1.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2026: Net Income towards Common Stockholders jumped 85.69% in 2022, then slumped 1108.39% in 2026.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$2.1 million in 2022, then soared by 60.51% to -$813000.0 in 2023, then plunged by 76.01% to -$1.4 million in 2024, then tumbled by 851.99% to -$13.6 million in 2025, then sank by 66.05% to -$22.6 million in 2026.
- Business Quant data shows FEED's Net Income towards Common Stockholders at -$22.6 million in Q1 2026, -$13.6 million in Q4 2025, and -$780000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 199.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | ENvue Medical | 2.71 Mn | 440,242.77 | -55,000.00 | -22.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.62 Mn |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | -780,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | -813,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.47 Mn |
| Sep 30, 2021 | -6.67 Mn |
| Jun 30, 2021 | -230,000.00 |